Ted Snelgrove

Ted Snelgrove is a seasoned professional with over 25 years of experience in molecular diagnostics and therapeutics, focusing on immunology, oncology, and reproductive medicine.

His educational background includes an MBA from the University of Michigan and a BS from the University of Idaho.

Throughout his career, Ted has held key leadership positions in various prestigious organizations, showcasing a diverse skill set and a deep understanding of the healthcare industry.

His previous roles include Chief Business Officer at Lexent Bio, Chief Commercial Officer at Guardant Health, Inc., Chief Business Officer at Counsyl, among others.

Ted Snelgrove's extensive experience also covers positions such as Oncology/Hematology Business Unit Head at Jazz Pharmaceuticals, Chief Executive Officer at CellScape Corporation, and Chief Commercial Officer at Crescendo Bioscience.

Prior to these roles, he has worked at Genomic Health, Inc., ALZA Corporation, Amgen, Inc., Immunex Corporation, Eli Lilly & Company, and even served in the US Navy in Aviation & Recruiting.

His career trajectory reflects a strong business acumen, strategic planning skills, and a focus on driving growth and innovation in the healthcare sector.